News/ News/ R&D BMS, BioMotiv alliance generates biopharma company Anteros Phil Taylor accelerator, Anteros Pharmaceuticals, BioMotiv, Bristol-Myers Squibb, fibrosis, inflammation, start-up 0 Comment A partnership between Bristol-Myers Squibb and drug development accelerator BioMotiv has yielded its first fruit just a few Share X BMS, BioMotiv alliance generates biopharma company Anteros https://pharmaphorum.com/news/bms-biomotiv-alliance-generates-biopharma-company-anteros/